Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Neurol Clin. 2022 Sep 28;40(4):755–768. doi: 10.1016/j.ncl.2022.03.006

Table 3.

ASMs tested in the apoptotic model.

Data on Risks Unknown Risks
 
Higher Risks Acetazolamide Lorazepam
Clonazepam Briviracetam Midazolam
Diazepam Cannabidiol Oxcarbazepine
Phenobarbital Cenobamate Perampanel
Phenytoin Clobazam Pregabalin
Valproate Diazepam Primidone
Vigabatrin Eslicarbazepine Rufinamide
Ethosuximide Stiripentol
Lower Risks Everolimus Sulthiame
Carbamazepine Felbamate Tiagabine
Lamotrigine Fenfluramine Zonisamide
Levetiracetam Gabapentin
Topiramate Lacosamide

Note that the model is predictive of effects in humans, but does not explore all possible mechanisms.

ASMs = antiseizure medications.